CA2053346C - Compositions de microcapsules pour traitement topique - Google Patents
Compositions de microcapsules pour traitement topiqueInfo
- Publication number
- CA2053346C CA2053346C CA002053346A CA2053346A CA2053346C CA 2053346 C CA2053346 C CA 2053346C CA 002053346 A CA002053346 A CA 002053346A CA 2053346 A CA2053346 A CA 2053346A CA 2053346 C CA2053346 C CA 2053346C
- Authority
- CA
- Canada
- Prior art keywords
- microcapsules
- liposomes
- mouth
- benefit agent
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909022298A GB9022298D0 (en) | 1990-10-15 | 1990-10-15 | Treatment composition |
| GBGB9022298.5 | 1990-10-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2053346A1 CA2053346A1 (fr) | 1992-04-16 |
| CA2053346C true CA2053346C (fr) | 1998-12-01 |
Family
ID=10683697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002053346A Expired - Fee Related CA2053346C (fr) | 1990-10-15 | 1991-10-11 | Compositions de microcapsules pour traitement topique |
Country Status (4)
| Country | Link |
|---|---|
| CA (1) | CA2053346C (fr) |
| DE (1) | DE69113570T2 (fr) |
| GB (1) | GB9022298D0 (fr) |
| PH (1) | PH31066A (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6416745B1 (en) * | 2001-05-03 | 2002-07-09 | Block Drug Company, Inc. | Dental composition for treating hypersensitive teeth |
-
1990
- 1990-10-15 GB GB909022298A patent/GB9022298D0/en active Pending
-
1991
- 1991-10-11 PH PH43286A patent/PH31066A/en unknown
- 1991-10-11 CA CA002053346A patent/CA2053346C/fr not_active Expired - Fee Related
- 1991-10-14 DE DE69113570T patent/DE69113570T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69113570D1 (de) | 1995-11-09 |
| DE69113570T2 (de) | 1996-03-14 |
| CA2053346A1 (fr) | 1992-04-16 |
| GB9022298D0 (en) | 1990-11-28 |
| PH31066A (en) | 1998-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0481701B1 (fr) | Composition de traitement | |
| AU674842B2 (en) | Cosmetic composition | |
| US5846951A (en) | Pharmaceutical compositions | |
| US4921644A (en) | Mucin directed lipsome | |
| US6565873B1 (en) | Biodegradable bioadhesive controlled release system of nano-particles for oral care products | |
| Holland et al. | Poly (ethylene glycol)− lipid conjugates promote bilayer formation in mixtures of non-bilayer-forming lipids | |
| AU2002305094B2 (en) | Liposome composition for improved intracellular delivery of a therapeutic agent | |
| US5030453A (en) | Stable plurilamellar vesicles | |
| Straubinger et al. | Liposome-based therapy of human ovarian cancer: parameters determining potency of negatively charged and antibody-targeted liposomes | |
| JP4076026B2 (ja) | リポソームディフェンシン | |
| AU2002305094A1 (en) | Liposome composition for improved intracellular delivery of a therapeutic agent | |
| JPH11503165A (ja) | レチノイド類とリポソームを含有するスキンケア組成物 | |
| CA2109952C (fr) | Compositions pharmaceutiques | |
| Jones et al. | Targeting and delivery of bactericide to adsorbed oral bacteria by use of proteoliposomes | |
| Jones et al. | The targeting of phospholipid liposomes to bacteria | |
| Robinson et al. | The use of immunoliposomes for specific delivery of antimicrobial agents to oral bacteria immobilized on polystyrene | |
| CA2053346C (fr) | Compositions de microcapsules pour traitement topique | |
| HU223475B1 (hu) | Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására | |
| JPH05506253A (ja) | 生体接着性リポソームの外用による持続的薬物放出 | |
| Jones et al. | The use of phospholipid liposomes for targeting to oral and skin-associated bacteria | |
| JP2003514843A (ja) | モジュラー標的化リポソーム送達システム | |
| JP2002535266A (ja) | 細胞保護およびH.pylori感染の処置のための標的化小胞構築物 | |
| Jiang et al. | Characterization of diphtheria toxin-induced lesions in liposomal membranes: an evaluation of the relationship between toxin insertion and “channel” formation | |
| Sospedra et al. | Physicochemical Behavior of Polylysine-[HAV-VP3 Peptide] Constructs at the Air− Water Interface | |
| Chandraprakash et al. | Effect of macrophage activation on plasma disposition of niosomal 3H-Methotrexate in sarcoma-180 bearing mice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |